AgomAb Therapeutics NV (AGMB)
11.68
-0.40
(-3.31%)
USD |
NASDAQ |
Sep 18, 13:09
AgomAb Therapeutics EPS Diluted (Quarterly) : -0.4156 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.4156 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.2568 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | 2.578 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.25M |
| Total Expenses (Quarterly) | 20.25M |
| Enterprise Value | 459.55M |
| Earnings Yield | -5.76% |